|
業務類別
|
Medical Devices |
|
業務概覽
|
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia,and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System. |
| 公司地址
| 7599 Anagram Drive, Eden Prairie, MN, USA, 55344 |
| 電話號碼
| +1 952 426-1383 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.n1mtc.com |
| 員工數量
| 18 |
| Mr. David A. Rosa |
Chief Executive Officer, President and Director |
美元 535.43K |
09/03/2026 |
| Mr. Mark Christianson |
Business Development Director, Medical Sales Liason |
-- |
09/03/2026 |
| Mr. Steve Mertens |
Chief Technology Officer |
-- |
09/03/2026 |
| Mr. Christopher R. Volker |
Chief Financial Officer |
美元 294.86K |
30/04/2026 |
| Ms. Emily J. Johns |
Chief Administrative Officer and General Counsel |
-- |
09/03/2026 |
|
|
| Mr. Jeffrey S. Mathiesen |
Independent Director |
09/03/2026 |
| Mr. Paul R. Buckman |
Chairman of the Board |
09/03/2026 |
| Mr. David A. Rosa |
Chief Executive Officer, President and Director |
09/03/2026 |
| Mr. Edward Andrle |
Independent Director |
09/03/2026 |
| Mr. Jason Richard Mills |
Director |
22/12/2025 |
|
|
|
|
